Company: CI
Filing Date: 2025-03-14
Form Type: DEF 14A
Source: 0001739940-25-000015
Chunk: 56

Company: Cigna Group
Filing Date: 2025-03-14
Form: DEF 14A
Chunk 56
---
 current target compensation for each officer. The Committee believes that tally sheets are a useful reference tool when considering whether compensation decisions reflect the Company’s compensation philosophy and performance, but are not a determining factor when making executive compensation decisions.

Annual Compensation Review and Competitiveness of Pay Positioning

Target total direct compensation consists of base salary, the annual incentive target, and the annual LTI target. The Committee (and the independent members of the Board with respect to Mr. Cordani) reviews and approves each of these amounts for the NEOs on an annual basis, generally seeking to target an executive officer’s total direct compensation in a competitive range around the 50th percentile of the relevant market data, although there may be variation in the target pay levels or mix due to factors such as performance, tenure in role, range of data available, negotiated arrangements, internal pay equity considerations, and market and economic conditions. When setting target total direct compensation, the Committee evaluates survey data and other public information, such as proxy data, available for both the compensation peer group and the general industry peer group.

The following adjustments were made to 2024 compensation:

• David M. Cordani . The Committee recommended, and the independent members of the Board approved, a modest adjustment to Mr. Cordani’s 2024 base salary and 2024 EIP target. Mr. Cordani’s base salary and EIP target had not been adjusted since 2018. This adjustment was made to maintain the competitive positioning of Mr. Cordani’s total target direct compensation.

• Brian C. Evanko . Effective February 2024, Mr. Evanko’s responsibilities were expanded as he assumed the role of P resident and Chief Executive Officer, Cigna Healthcare, in addition to his role as Executive Vice President and Chief Financial Officer, The Cign a Group. As previously disclosed, in connection with the expansion of Mr. Evanko’s responsibilities, as well as to position his compensation within a competitive range of the market for such roles, the Committee approved adjustments to his base salary, as well as to his 2024 EIP and 2024 LTI targets.

• Noelle K. Eder . The Committee approved adjustments to Ms. Eder’s base salary to ensure that her compensation reflected the scope of the responsibilities of her role leading the Company’s global technology and operations organizations, as well as to position her compensation within a competitive range of the market for her role.

| 60 |     | The Cigna Group| 2025 Notice of Annual Meeting of